Core Insights - The Biotech Index (970038) closed at 2182.31 points, down 0.94%, with a trading volume of 13.462 billion yuan and a turnover rate of 1.08% [1] - Among the index constituents, 7 stocks rose while 42 stocks fell, with Xinlitai leading the gainers at 0.83% and Hualan Biological leading the decliners at 5.98% [1] Index Constituents Summary - The top ten constituents of the Biotech Index include: - Mindray Medical (sz300760) with a weight of 12.58%, latest price at 204.81, and a decline of 0.92% [1] - Changchun High-tech (sz000661) with a weight of 4.87%, latest price at 102.32, and a decline of 0.27% [1] - Shimeiao (sz002252) with a weight of 4.74%, latest price at 6.70, and a decline of 0.30% [1] - Kanglong Chemical (sz300759) with a weight of 4.55%, latest price at 29.16, and a decline of 1.22% [1] - Tigermed (sz300347) with a weight of 4.54%, latest price at 52.37, and a decline of 2.44% [1] - Shenzhen Technology (sz000021) with a weight of 4.16%, latest price at 23.90, and a decline of 1.77% [1] - Muyuan Foods (sz002714) with a weight of 3.62%, latest price at 48.45, and a decline of 0.31% [1] - Lepu Medical (sz300003) with a weight of 3.19%, latest price at 16.11, and a decline of 1.29% [1] - Aimeike (sz300896) with a weight of 3.16%, latest price at 155.51, and an increase of 0.58% [1] - Yuyue Medical (sz002223) with a weight of 3.07%, latest price at 35.28, and a decline of 0.20% [1] Capital Flow Analysis - The Biotech Index constituents experienced a net outflow of 1.382 billion yuan from major funds, while retail investors saw a net inflow of 1.358 billion yuan [1] - Notable capital flows include: - Aimeike (sz300896) had a net inflow of 26.5772 million yuan from major funds, but a net outflow from retail investors of 20.4422 million yuan [2] - Changchun High-tech (sz000661) saw a net inflow of 8.8418 million yuan from major funds, with a slight net inflow from retail investors of 186.25 thousand yuan [2] - Other stocks like Furuisi (sz300049) and Yuyue Medical (sz002223) also showed mixed capital flows with significant net outflows from retail investors [2]

Core Insights - The report emphasizes the cyclical nature of the pig farming industry, indicating that the downward cycle is nearing its end, with a potential upward turning point expected in 2026 [3][19] - The pet economy remains a key growth area, highlighting investment opportunities in niche sectors [4] Group 1: Industry Overview - The agricultural sector, particularly the pig farming segment, is experiencing a downturn, with 2025 expected to see continued losses, leading to a price bottom in the first half of 2026 [5][19] - The chicken farming sector is also under pressure, with expectations of supply-side stabilization and demand recovery in 2026 [20] - The cattle farming sector is projected to face a supply contraction starting in 2026, which may last until 2027 [21] Group 2: Investment Opportunities - The pet food industry is anticipated to maintain its growth trajectory, with leading companies increasing their market share despite challenges in export performance [5][4] - The blueberry market in Yunnan is expected to see profit realization from 2024 to 2025, with growth potential continuing into 2026-2027 [5] - The artificial cultivation of Cordyceps is gaining traction as natural production declines, with early movers in this space likely to see performance improvements [5] Group 3: Key Companies to Watch - The report identifies several key companies for investment consideration, including Muyuan Foods, Wens Foodstuff Group, DeKang Agriculture, TianKang Biological, and others in the pet food sector [5]

Core Insights - The swine industry is experiencing significant losses, with the average selling price of live pigs dropping to 11.56 yuan/kg, leading to a loss of 71.95 yuan per head for self-bred pigs [1] - Analysts suggest that the current oversupply and weak demand may result in a "non-peak" season for pork prices in Q4, indicating potential investment opportunities in the sector [1] - The industry is expected to undergo capacity reduction, which may lead to an upward adjustment of pork price levels by 2026, benefiting low-cost producers [1] Group 1: Market Performance - As of November 18, 2025, the China Livestock Breeding Index (930707) showed mixed performance among its constituent stocks, with Muyuan Foods (002714) leading with a 0.43% increase [1] - The Livestock ETF (516760) was quoted at 0.7 yuan [1] - The top ten weighted stocks in the index accounted for 65.58% of the total index weight, indicating a concentration in a few key players [2] Group 2: Stock Performance - The stock performance of key companies includes: - Muyuan Foods (002714): +0.43%, weight 11.37% - Haida Group (002311): +0.34%, weight 9.52% - Biological Shares (600201): +0.25%, weight 3.91% - Other notable declines include New Hope (000876): -1.01% and Tian康 Biological (002100): -1.96% [4]

Core Insights - The feed sector experienced a slight increase of 0.07% on November 17, with Tianma Technology leading the gains [1] - The Shanghai Composite Index closed at 3972.03, down 0.46%, while the Shenzhen Component Index closed at 13202.0, down 0.11% [1] Feed Sector Performance - Tianma Technology (603668) closed at 15.33, up 6.16% with a trading volume of 898,500 shares and a transaction value of 1.402 billion [1] - Other notable performers included: - Zhongchong Co., Ltd. (002891) at 59.69, up 3.86% [1] - Zhenghong Technology (000702) at 7.65, up 1.06% [1] - Petty Holdings (300673) at 17.70, up 0.91% [1] - Guibao Pet (301498) at 72.62, up 0.54% [1] Capital Flow Analysis - The feed sector saw a net outflow of 118 million from institutional investors and 78.86 million from retail investors, while retail investors had a net inflow of 197 million [2] - The capital flow for key stocks included: - Tianma Technology had a net inflow of 1.03 billion from institutional investors, but a net outflow of 130 million from retail investors [3] - Haida Group (002311) had a net inflow of 11.08 million from institutional investors [3] - Other stocks like Petty Holdings and Zhenghong Technology experienced net outflows from institutional investors [3]

Core Viewpoint - The pig farming industry is experiencing significant losses, leading to accelerated capacity reduction, while the dairy market faces supply-demand imbalances, impacting livestock numbers and prices [1][2]. Group 1: Pig Farming Industry - The pig farming sector has been in a state of continuous loss for several weeks, with the national average price of commercial pigs dropping by 28% year-on-year in Q3 2025, and major listed pig companies seeing a 68% decline in net profit [1]. - Current asset-liability ratios in the industry are well-controlled, but there is a noticeable divergence between the growth rate of pig sales and cost control, indicating a shift from cyclical to efficiency-driven competition [1]. - Due to ongoing losses and policy guidance, it is expected that capacity reduction will accelerate, laying the groundwork for a future price recovery [1]. Group 2: Dairy and Beef Market - Dairy prices have fallen below the previous cycle's bottom, highlighting a significant supply-demand imbalance, with dairy cow inventory decreasing by over 8% cumulatively in October [1]. - The beef market is entering an upward price trend, with expectations of price fluctuations in November and December due to the winter consumption peak [1]. - Long-term projections suggest that the beef cycle's price increase may exceed expectations, particularly benefiting companies with cow resources [1]. Group 3: Index and Stock Performance - The CSI Livestock Breeding Index (930707) shows mixed performance among its constituent stocks, with Tianma Technology (603668) leading with a 5.06% increase, while Jinnong (002548) is the biggest loser [1]. - As of October 31, 2025, the top ten weighted stocks in the CSI Livestock Breeding Index account for 65.58% of the index, with Muyuan Foods (002714) and Wens Foodstuffs (300498) being the largest components [2]. - The performance of the top ten stocks varies, with Muyuan Foods down 3.63% and Wens Foodstuffs down 2.10% [3].

Core Insights - The feed sector experienced a decline of 0.24% on November 14, with Zhongchong Co., Ltd. leading the losses [1][2] - The Shanghai Composite Index closed at 3990.49, down 0.97%, while the Shenzhen Component Index closed at 13216.03, down 1.93% [1] Market Performance - Tianma Technology (603668) saw a price increase of 3.29%, closing at 14.44, with a trading volume of 446,400 shares and a turnover of 642 million yuan [1] - Other notable gainers included Kesi Thought (001313) with a 3.16% increase and Baiyang Co., Ltd. (002696) with a 0.84% increase [1] - Zhongchong Co., Ltd. (002891) led the declines with a drop of 2.53%, closing at 57.47, with a trading volume of 33,300 shares and a turnover of 193 million yuan [2] Capital Flow - The feed sector experienced a net outflow of 80.91 million yuan from institutional investors and 50.57 million yuan from retail investors, while individual investors saw a net inflow of 131 million yuan [2] - Tianma Technology had a net inflow of 32.96 million yuan from institutional investors, while Hai Da Group (002311) had a net inflow of 15.96 million yuan [3] - Conversely, companies like Boen Group (001366) and Hefa Co., Ltd. (603609) experienced significant net outflows from institutional and retail investors [3]

Summary of JinKang Biological Conference Call Company Overview - JinKang Biological is a comprehensive agricultural enterprise involved in oil processing, corn procurement, pig farming, feed production, and veterinary biological products [2][3] - Established in 2000, the company has over 50 large-scale breeding bases across China and ranks among the top 20 in the domestic pig farming industry [3] Key Financial Metrics - In 2024, JinKang is expected to have a pig output of 3.03 million heads, with feed sales of 2.83 million tons and veterinary business revenue of 990 million yuan [2] - The gross profit contributions for 2024 are as follows: - Pig farming: 900 million yuan (46%) - Feed business: 580 million yuan (30%) - Veterinary business: 620 million yuan (24%) [2][5] - The company reported a net loss of 1.363 billion yuan in 2023 due to pig price fluctuations, but performance is expected to improve in 2024 [2][5] - The projected net profit for 2024 is approximately 600 million yuan, with an expected decrease to 500 million yuan in 2025 [4][9] Industry Context - The industry is currently at the bottom of the cycle, expected to last until mid-2026, with a recovery anticipated in the second half of 2026 [2][8] - The duration of industry losses and the degree of capacity reduction are key indicators for recovery [8] Competitive Advantages - JinKang Biological has three core competitive advantages: 1. Integrated operational model leading to stable performance and a lighter asset-liability structure [6][7] 2. Geographic advantages with production concentrated in Xinjiang, Gansu, and Henan, providing low-density farming environments and biosecurity [7] 3. Strong cost control, with total comprehensive costs expected to decrease from 15 yuan per kg to 13.5 yuan by the end of 2024, and further to 12 yuan by Q3 2025 [7] Valuation and Investment Potential - The current price-to-earnings (P/E) ratio is approximately 17, significantly lower than the industry average of 33, indicating potential for value investment [4][9] - Factors supporting investment in JinKang include the upcoming industry recovery, stable operational model, core competitive advantages, and undervalued market position [9]

Group 1 - The China Livestock Breeding Index (930707) increased by 0.43% as of November 13, 2025, with notable gains in constituent stocks such as Bio-Stock (600201) up 8.27%, Huaying Agriculture (002321) up 4.82%, and others [1] - The price difference between standard pigs and fat pigs is currently larger than the same period last year, with a standard fat price difference of -0.68 yuan/kg as of November 7, indicating potential seasonal benefits for fat pigs as temperatures drop [1] - The weekly slaughter volume in the downstream market has shown a slight recovery of 0.27% compared to the previous week, suggesting a stabilization in demand [1] Group 2 - As of October 31, 2025, the top ten weighted stocks in the China Livestock Breeding Index accounted for 65.58% of the index, including companies like Muyuan Foods (002714) and Wens Foodstuff Group (300498) [2] - The index tracks companies involved in livestock feed, veterinary drugs, and livestock farming, reflecting the overall performance of listed companies in the livestock breeding sector [2]

Core Viewpoint - TianKang Biological is actively exploring and developing its business in the Chinese food and cooked food sector, although this segment is still in the early stages of development and represents a small portion of the company's overall sales [1] Company Summary - The company has made significant efforts in the Chinese food and cooked food product areas [1] - Currently, the sales revenue from cooked food is approximately 6 million [1] - The overall sales scale of this segment is relatively small compared to the company's main business [1]

Market Overview - The feed sector experienced a decline of 0.91% on November 12, with Bangji Technology leading the drop [1] - The Shanghai Composite Index closed at 4000.14, down 0.07%, while the Shenzhen Component Index closed at 13240.62, down 0.36% [1] Individual Stock Performance - Jin Xin Nong (002548) saw a closing price of 5.69, with an increase of 3.27% and a trading volume of 486,900 shares, totaling a transaction value of 273 million yuan [1] - Bangji Technology (603151) closed at 19.91, down 7.18%, with a trading volume of 99,600 shares and a transaction value of 200 million yuan [2] - Aonong Biological (603363) closed at 5.44, down 6.21%, with a trading volume of 1,185,900 shares and a transaction value of 661 million yuan [2] Capital Flow Analysis - The feed sector experienced a net outflow of 204 million yuan from main funds, while retail investors saw a net inflow of 201 million yuan [2] - The main funds showed a negative net flow for several stocks, including Jin Xin Nong with a net outflow of 40.4 million yuan [3] - Retail investors contributed positively to stocks like Petty Co. (300673), which had a net inflow of 24.3 million yuan from retail investors despite a main fund outflow of 8.1 million yuan [3]